115 related articles for article (PubMed ID: 3348429)
21. Partial reversal of hypoxic pulmonary hypertension by heparin.
Hassoun PM; Thompson BT; Hales CA
Am Rev Respir Dis; 1992 Jan; 145(1):193-6. PubMed ID: 1731584
[TBL] [Abstract][Full Text] [Related]
22. Neurohumoral contributions to chronic angiotensin-induced hypertension.
Bruner CA; Fink GD
Am J Physiol; 1986 Jan; 250(1 Pt 2):H52-61. PubMed ID: 2867686
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension.
van Suylen RJ; Smits JF; Daemen MJ
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1423-8. PubMed ID: 9603118
[TBL] [Abstract][Full Text] [Related]
24. Intermittent high altitude hypoxia.
Widimsky J; Ostádal B; Urbanová D; Ressl J; Procházka J; Pelouch V
Chest; 1980 Mar; 77(3):383-9. PubMed ID: 6102021
[TBL] [Abstract][Full Text] [Related]
25. BQ123, an ETA-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats.
Bonvallet ST; Zamora MR; Hasunuma K; Sato K; Hanasato N; Anderson D; Sato K; Stelzner TJ
Am J Physiol; 1994 Apr; 266(4 Pt 2):H1327-31. PubMed ID: 8184910
[TBL] [Abstract][Full Text] [Related]
26. Effect of heparin and warfarin on chronic hypoxic pulmonary hypertension and vascular remodeling in the guinea pig.
Hassoun PM; Thompson BT; Steigman D; Hales CA
Am Rev Respir Dis; 1989 Mar; 139(3):763-8. PubMed ID: 2923376
[TBL] [Abstract][Full Text] [Related]
27. Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension.
Chassagne C; Eddahibi S; Adamy C; Rideau D; Marotte F; Dubois-Randé JL; Adnot S; Samuel JL; Teiger E
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):323-32. PubMed ID: 10696069
[TBL] [Abstract][Full Text] [Related]
28. BAY 41-2272 inhibits the development of chronic hypoxic pulmonary hypertension in rats.
Thorsen LB; Eskildsen-Helmond Y; Zibrandtsen H; Stasch JP; Simonsen U; Laursen BE
Eur J Pharmacol; 2010 Nov; 647(1-3):147-54. PubMed ID: 20828552
[TBL] [Abstract][Full Text] [Related]
29. Protective effects of vasonatrin peptide against hypobaric hypoxia-induced pulmonary hypertension in rats.
Yu J; Feng HS; Chen BY; Qu P; Liu LB; Chen JK; Tie R; Huang XJ; Zhao YF; Zhu XX; Zhu MZ
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):69-74. PubMed ID: 19566831
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung.
Zhao L; al-Tubuly R; Sebkhi A; Owji AA; Nunez DJ; Wilkins MR
Br J Pharmacol; 1996 Nov; 119(6):1217-22. PubMed ID: 8937726
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary vascular reactivity in Fischer rats.
He LS; Chang SW; Voelkel NF
J Appl Physiol (1985); 1991 Apr; 70(4):1861-6. PubMed ID: 2055865
[TBL] [Abstract][Full Text] [Related]
32. Chronic hypoxic pulmonary hypertension. Is thrombin involved?
Hampl V; Archer SL; Bach R; Nelson DP; Weir EK
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1043-8. PubMed ID: 8214923
[TBL] [Abstract][Full Text] [Related]
33. The effect of isoproterenol on the development and recovery of hypoxic pulmonary hypertension. A structural and hemodynamic study.
Fried R; Reid LM
Am J Pathol; 1985 Oct; 121(1):102-11. PubMed ID: 4050970
[TBL] [Abstract][Full Text] [Related]
34. Reduction of chronic hypoxic pulmonary hypertension in the rat by an inhibitor of collagen production.
Kerr JS; Ruppert CL; Tozzi CA; Neubauer JA; Frankel HM; Yu SY; Riley DJ
Am Rev Respir Dis; 1987 Feb; 135(2):300-6. PubMed ID: 3813190
[TBL] [Abstract][Full Text] [Related]
35. BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats.
Deruelle P; Balasubramaniam V; Kunig AM; Seedorf GJ; Markham NE; Abman SH
Biol Neonate; 2006; 90(2):135-44. PubMed ID: 16582538
[TBL] [Abstract][Full Text] [Related]
36. Effect of verapamil on pulmonary hypertension and right ventricular hypertrophy induced in rats by intermittent high altitude hypoxia.
Ostádal B; Ressl J; Urbanová D; Procházka J; Pelouch V; Widimský J
Respiration; 1981; 42(4):221-7. PubMed ID: 6460304
[TBL] [Abstract][Full Text] [Related]
37. Dissociation of pulmonary vascular remodeling and right ventricular pressure in tissue angiotensin-converting enzyme-deficient mice under conditions of chronic alveolar hypoxia.
van Suylen RJ; Aartsen WM; Smits JF; Daemen MJ
Am J Respir Crit Care Med; 2001 Apr; 163(5):1241-5. PubMed ID: 11316665
[TBL] [Abstract][Full Text] [Related]
38. Diethylcarbamazine inhibits acute and chronic hypoxic pulmonary hypertension in awake rats.
Morganroth ML; Stenmark KR; Morris KG; Murphy RC; Mathias M; Reeves JT; Voelkel NF
Am Rev Respir Dis; 1985 Apr; 131(4):488-92. PubMed ID: 3994144
[TBL] [Abstract][Full Text] [Related]
39. Effect of ligustrazine on pulmonary vascular changes induced by chronic hypoxia in rats.
Cai YN; Barer GR
Clin Sci (Lond); 1989 Nov; 77(5):515-20. PubMed ID: 2582722
[TBL] [Abstract][Full Text] [Related]
40. U50,488H depresses pulmonary pressure in rats subjected to chronic hypoxia.
Pei JM; Sun X; Guo HT; Ma S; Zang YM; Lu SY; Bi H; Wang YM; Ma H; Ma XL
J Cardiovasc Pharmacol; 2006 Apr; 47(4):594-8. PubMed ID: 16680074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
